-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
-
Summary
-
Protara Therapeutics, Inc. quarterly/annual Net Income (Loss) Attributable to Parent history and growth rate from Q1 2013 to Q4 2024.
- Protara Therapeutics, Inc. Net Income (Loss) Attributable to Parent for the quarter ending December 31, 2024 was -$12.8M, a 24.9% decline year-over-year.
- Protara Therapeutics, Inc. Net Income (Loss) Attributable to Parent for the twelve months ending December 31, 2024 was -$44.6M, a 10.3% decline year-over-year.
- Protara Therapeutics, Inc. annual Net Income (Loss) Attributable to Parent for 2024 was -$44.6M, a 10.3% decline from 2023.
- Protara Therapeutics, Inc. annual Net Income (Loss) Attributable to Parent for 2023 was -$40.4M, a 38.7% increase from 2022.
- Protara Therapeutics, Inc. annual Net Income (Loss) Attributable to Parent for 2022 was -$66M, a 39.6% decline from 2021.
Net Income (Loss) Attributable to Parent, Trailing 12 Months (USD)
Net Income (Loss) Attributable to Parent, Quarterly (USD)
Net Income (Loss) Attributable to Parent, YoY Quarterly Growth (%)